Israel’s Clew Medical (reported here previously) has just received US FDA emergency use authorization to remotely identify patients who are likely to experience common coronavirus complications, including respiratory failure and hemodynamic instability.

https://www.calcalistech.com/ctech/articles/0,7340,L-3833655,00.html